Rigel Pharmaceuticals, Inc. (RIGL) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $32.85 +2.40%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
PLCE, COE, JVA, More
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q2 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- BIG3 Basketball to go public via Graf Global merger at $290 million
- UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
